-
CONCOMITANT USE OF DPP4 INHIBITORS AND RAAS INHIBITORS AND RISK OF ANGIOEDEMA: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
THE ICEBERG STUDY: VALIDATING PATIENT RIGHT OF ACCESS DATA COLLECTION AS A NOVEL METHOD FOR LONGITUDINAL RWD GENERATION IN CLINICAL RESEARCH
Mar 18, 2026, 21:38 PM -
HEALTHCARE UTILIZATION AND COSTS ATTRIBUTABLE TO CLINICALLY IMPACTFUL IMMUNE-RELATED ADVERSE EVENTS AMONG OLDER ADULTS WITH ADVANCED NON-SMALL CELL LUNG CANCER TREATED WITH IMMUNE CHECKPOINT INHIBITORS
Mar 18, 2026, 21:38 PM -
FDA APPROVALS OF SPECIALTY DRUGS, 2000-2024
Mar 18, 2026, 21:38 PM -
DEVELOPMENT AND VALIDATION OF A NOMOGRAM TO PREDICT OVERALL SURVIVAL IN NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
MEAN OVERALL SURVIVAL FROM THE PHASE 3 MIRASOL TRIAL OF MIRVETUXIMAB SORAVTANSINE VS INVESTIGATOR’S CHOICE OF CHEMOTHERAPY IN WOMEN WITH FR?-HIGH PLATINUM-RESISTANT OVARIAN CANCER (GOG 3045/ENGOT-OV55; NCT04209855)
Mar 18, 2026, 21:38 PM -
CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN CISPLATIN ELIGIBLE VERSUS CISPLATIN INELIGIBLE MUSCLE INVASIVE BLADDER CANCER PATIENTS WITH INTENT FOR RESECTION: A MULTICOUNTRY RETROSPECTIVE CHART REVIEW IN EUROPE
Mar 18, 2026, 21:38 PM -
ACCESS CHALLENGES IDENTIFIED BY WOMEN WITH CARDIOVASCULAR DISEASE: FINDINGS FROM THE SECOND PHASE OF THE PATIENT-LED INSIGHTS AND PATIENT EXPERIENCES WITH CARDIOVASCULAR DISEASE (IPEC2) INITIATIVE
Mar 18, 2026, 21:38 PM -
REAL-WORLD SURVIVAL AND PREDICTORS OF MORTALITY IN HEMATOLOGIC MALIGNANCIES DURING AN ERA OF THERAPEUTIC ADVANCEMENT AND HEALTHCARE DISRUPTION: A POPULATION-BASED SEER STUDY
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN PINEAL NEOPLASM AND ALZHEIMER’S DISEASE PROGRESSION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT: A POPULATION-BASED COHORT STUDY
Mar 18, 2026, 21:38 PM -
IMPACT OF COVID-19 PANDEMIC ON HEALTHCARE UTILIZATION IN THE US AS OBSERVED IN FEDERATED ELECTRONIC HEALTH RECORDS: 2016 TO 2022
Mar 18, 2026, 21:38 PM -
CHARACTERIZING THE PATIENTS WITH FIBROMYALGIA: A US REAL-WORLD CLAIMS ANALYSIS
Mar 18, 2026, 21:38 PM -
POST-2020 REAL-WORLD EVIDENCE ON PHARMACOTHERAPIES FOR CHRONIC LYMPHOCYTIC LEUKEMIA: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
HOSPITALIZATION COSTS ASSOCIATED WITH 30-DAY UNPLANNED READMISSIONS AND POTENTIALLY PREVENTABLE READMISSIONS IN US OLDER PATIENTS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
Mar 18, 2026, 21:38 PM -
ASSESSING THE CONCORDANCE BETWEEN SELF-REPORTED NICOTINE PRODUCT USE AND EMR DIAGNOSIS CODES IN THE ALL OF US RESEARCH PROGRAM
Mar 18, 2026, 21:38 PM -
VALIDATION OF AN AGENTIC LARGE LANGUAGE MODEL (LLM) SYSTEM IN THE EXTRACTION STAGE OF A REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR): A SOLUTION TO INSTANT AND EASY ACCESS TO CLINICAL TRIAL DATA (CTD)
Mar 18, 2026, 21:38 PM -
HEALTH-RELATED QUALITY OF LIFE AND EMOTION REGULATION STRATEGIES IN ADOLESCENTS WITH DEPRESSION IN CHINA: A CROSS-SECTIONAL STUDY
Mar 18, 2026, 21:38 PM -
STRATEGIC MARKET ACCESS PLANNING IN BREAST AND LUNG CANCER ENABLED BYREAL-TIMEAI-ASSISTEDLIVINGSYSTEMATICLITERATUREREVIEW (REAL-SLR)SYSTEM
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR MENTAL HEALTH DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COMPARING OUTCOME MODELING STRATEGIES FOR ZERO-INFLATED ABSENTEEISM IN REAL-WORLD DATA: IMPLICATIONS FOR INFERENCE ON ANXIETY SEVERITY
Mar 18, 2026, 21:38 PM
